Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis.

Cardiovasc Diabetol · 2025 · PMC12374271 · PMID 40849664

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

The study found that after a median 3.2 years of follow-up, participants randomized to EQW had a numerically lower incidence of major adverse CV events (MACE) and a nominally significant reduction in all-cause mortality (ACM) [ 7 ].

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.